drugset / Trial / NCT03201757
Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the long-term safety, tolerability, and durability of treatment effect of ALKS 3831 in subjects with schizophrenia, schizophreniform disorder, or bipolar I disorder
Timeline
- Start
- 2017-06-15
- Primary completion
- 2023-09-06
- Completion
- 2023-09-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olanzapine | Small molecule | — | Oral |
| Subject | Samidorphan | Small molecule | — | Oral |